ClinicalTrials HQ

Talazoparib Plus Enzalutamide After Progression to Prior ARPi in Metastatic Prostate Cancer

Talazoparib Plus Enzalutamide After Progression to Prior ARPi in Metastatic Prostate Cancer

Recruiting · NCT06582628 · Registry updated 2026-10-05
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Talazoparib Plus Enzalutamide After Progression to Prior ARPi in Metastatic Prostate CancerGenital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, metastatic prostate carcinoma, neoplasm, prostate cancer, prostate disorderRecruitingPhase 22026-10-05NCT06582628

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Fundacion Oncosur2

19 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Centre Oscar LambretLilleFrance61
Consorcio Corporación Sanitaria Parc TaulíSabadellSpain1
Hospital 12 de OctubreMadridSpain13
Hospital Clínico San CarlosMadridSpain29
Hospital Clínico y Provincial de BarcelonaBarcelonaSpain2
Hospital del MarBarcelonaSpain17
Hospital Fundación Jiménez DíazMadridSpain5
Hospital Universitario CrucesBarakaldoSpain10
Hospital Universitario de Jerez de la FronteraCadizSpain1
Hospital Universitario La PazMadridSpain46
Hospital Universitario Marqués de ValdecillaSantanderSpain40
Hospital Universitario Miguel ServetZaragozaSpain1
Hospital Universitario Virgen de la VictoriaMálagaSpain24
Hôpital Saint JosephParisFrance4
Hôpital Universitaire de BrestBrestFrance1
Hôpitaux Universitaire de StrasbourgStrasbourgFrance1
Institut BergoniéBordeauxFrance47
Institut Català d'Oncologia (ICO)BadalonaSpain1
Institut Gustave RoussyVillejuifFrance58